Armata Pharmaceuticals (ARMP) Receivables (2013 - 2026)
Armata Pharmaceuticals (ARMP) posted Receivables of $100000.0 for Q1 2026, down 80.0% sequentially from $500000.0 in Q4 2025, and down 50.0% YoY from $200000.0 in Q1 2025.
Armata Pharmaceuticals (ARMP) Receivables (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported Receivables for 9 years, with the latest figure at $100000.0 in Q1 2026.
- Quarterly Receivables fell 50.0% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100000.0 (down 50.0% YoY) and the FY2025 annual result came in at $500000.0, down 65.37% from the prior year.
- Receivables slipped to $100000.0 in Q1 2026 per ARMP's latest filing, from $500000.0 in the prior quarter.
- Over five years, Receivables peaked at $4.9 million in Q4 2023 and troughed at $100000.0 in Q1 2026.
- A 4-year average of $1.8 million and a median of $1.3 million in 2024 frame the typical range for Receivables.
- The sharpest annual moves came in 2024 and 2025: Receivables plunged 70.31% in 2024, then jumped 76.28% in 2025.
- Over 4 years, Receivables stood at $4.9 million in 2023, then slumped by 70.31% to $1.4 million in 2024, then tumbled by 65.37% to $500000.0 in 2025, then tumbled by 80.0% to $100000.0 in 2026.
- According to Business Quant data, Receivables over the past three periods registered $100000.0, $500000.0, and $2.2 million for Q1 2026, Q4 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.69 Bn | 130.84 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.29 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.79 Bn | 59.60 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 59.44 Bn | 54.31 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 30.92 Bn | 27.61 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.10 Bn | 9.71 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.33 Bn | 26.17 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.00 Bn | 26.17 Bn | - | - |
| 10 | Armata Pharmaceuticals | 164.52 Mn | 140.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 500,000.00 |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 1.44 Mn |
| Sep 30, 2024 | 3.82 Mn |
| Jun 30, 2024 | 1.25 Mn |
| Dec 31, 2023 | 4.86 Mn |
| Mar 31, 2017 | 15,000.00 |
| Dec 31, 2016 | 12,000.00 |
| Sep 30, 2016 | 24,000.00 |
| Jun 30, 2016 | 18,000.00 |
| Mar 31, 2016 | 14,000.00 |
| Dec 31, 2015 | 125,000.00 |
| Sep 30, 2015 | 40,000.00 |
| Dec 31, 2014 | 100,000.00 |
| Sep 30, 2014 | 27,000.00 |
| Jun 30, 2014 | 136,000.00 |
| Mar 31, 2014 | 12,000.00 |
| Dec 31, 2013 | 8,000.00 |